Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

K/S BIOGRAFERNE I HELSINGØR

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   2.8% 2.8% 2.8% 2.8% 2.8% 2.8% 2.8% 2.8%   Bankruptcy risk   1.0% 0.9% 1.4% 1.1% 2.4% 1.1% 29.3% 28.9%   Credit score (0-100)   89 89 77 82 63 81 1 2   Credit rating   A A A A BBB A C B   Credit limit (kDKK)   552.4 647.6 26.2 266.0 0.0 257.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   5,797 6,752 3,464 4,421 4,088 5,942 0.0 0.0   EBITDA   3,350 4,206 1,271 2,702 1,497 2,991 0.0 0.0   EBIT   3,075 3,568 605 2,080 600 1,346 0.0 0.0   Pre-tax profit (PTP)   3,055.0 3,552.8 588.4 2,064.4 474.5 892.0 0.0 0.0   Net earnings   3,055.0 3,552.8 588.4 2,064.4 474.5 892.0 0.0 0.0   Pre-tax profit without non-rec. items   3,055 3,553 588 2,064 475 892 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   3,614 5,244 4,578 4,392 12,074 13,427 0.0 0.0   Shareholders equity total   4,923 5,421 2,456 3,932 2,343 2,760 0.0 0.0   Interest-bearing liabilities   0.0 0.0 0.0 0.0 4,800 7,834 0.0 0.0   Balance sheet total (assets)   7,953 8,861 6,316 7,628 16,586 17,482 0.0 0.0   Net Debt   -3,380 -2,669 -1,347 -2,538 1,579 4,684 0.0 0.0     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   5,797 6,752 3,464 4,421 4,088 5,942 0.0 0.0   Gross profit growth   6.0% 16.5% -48.7% 27.6% -7.5% 45.4% -100.0% 0.0%   Employees   4 4 4 4 4 7 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 75.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   7,953 8,861 6,316 7,628 16,586 17,482 0 0   Balance sheet change%   4.2% 11.4% -28.7% 20.8% 117.4% 5.4% -100.0% 0.0%   Added value   3,349.5 4,205.9 1,271.2 2,702.5 1,221.7 2,990.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   2,495 992 -1,332 -808 6,784 -292 -13,427 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   53.0% 52.8% 17.5% 47.1% 14.7% 22.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   39.5% 42.4% 8.0% 29.8% 5.0% 8.1% 0.0% 0.0%   ROI %   63.7% 69.0% 15.4% 65.1% 10.8% 15.6% 0.0% 0.0%   ROE %   63.3% 68.7% 14.9% 64.6% 15.1% 35.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   61.9% 61.2% 38.9% 51.6% 14.1% 15.8% 0.0% 0.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -100.9% -63.5% -105.9% -93.9% 105.5% 156.6% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 204.9% 283.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 5.2% 7.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.4 1.0 0.4 0.8 0.5 0.3 0.0 0.0   Current Ratio   1.4 1.1 0.5 0.9 0.5 0.4 0.0 0.0   Cash and cash equivalent   3,380.5 2,668.9 1,346.7 2,537.9 3,221.4 3,150.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,309.0 176.7 -2,121.5 -459.9 -4,931.0 -6,666.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   837 1,051 318 676 305 427 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   837 1,051 318 676 374 427 0 0   EBIT / employee   769 892 151 520 150 192 0 0   Net earnings / employee   764 888 147 516 119 127 0 0